Too much acid reflux can result in both sores and ulcers. While Zantac and ranitidine once played a helpful role in treating this condition, the parents of children who experience this condition must now pursue other safer options. Birth defects involve harm to a child that occurred before birth such as exposure to a harmful drug or something that happened during the pregnancy. Birth injuries, however, are typically caused by an error that occurred during the delivery of the child.
Several types of birth defects are associated with prolonged usage of ranitidine or Zantac during pregnancy. While there are many potential defects, some of the most common birth defects associated with exposure to NDMA include:. If your pregnancy resulted in a birth defect after taking ranitidine or Zantac or you or your child developed cancer after prolonged usage of these medications, you might be able to pursue compensation.
If you satisfy the following criteria, you will likely be able to seek compensation:. Depending on the details of your case, we may be able to help you recover costs and losses such as:. We can tell you more about what damages you may qualify to pursue. Some of these manufacturers include GlaxoSmithKline, Novartis, Sanofi who manufactured the brand-name Zantac drug , and other manufacturers who produced generic ranitidine and ranitidine equivalents. We can tell you more about who could be liable in your case.
Cases involving negligent pharmaceutical companies can be especially complex to prove. Gathering compelling evidence is key in a dangerous drug case.
If you or a loved one has been injured by Zantac or any other defective drug, you can quickly find yourself facing various complications. If you retain the help of a defective drug attorney on our team, we can help you with the most challenging cases.
We have recovered millions for injury victims and we will seek the best possible results for you. For a free legal consultation, call Elmiron Linked with Dangerous Vision Disorder In the last several months, mass tort litigation involving the Elmiron brand name medication has commenced in United States federal court. The overall malformation rate was 4.
The relative risks for nongenetic congenital malformations associated with the use of cimetidine, omeprazole, and ranitidine were 1. No specific grouping in the distribution of malformations was observed in any of the three exposed groups.
Moreover, no relation was found between drug exposure and preterm delivery or growth retardation. Take our survey. Page last reviewed: 16 July Next review due: 16 July Help us improve our website Can you answer a quick question about your visit today? Related conditions Heartburn and acid reflux Indigestion Stomach ulcer.
0コメント